Victory Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $152K | Sell |
2,673
-11,735
| -81% | -$668K | ﹤0.01% | 2283 |
|
2025
Q1 | $807K | Hold |
14,408
| – | – | ﹤0.01% | 1894 |
|
2024
Q4 | $886K | Hold |
14,408
| – | – | ﹤0.01% | 1858 |
|
2024
Q3 | $964K | Buy |
14,408
+11,735
| +439% | +$785K | ﹤0.01% | 1791 |
|
2024
Q2 | $179K | Buy |
2,673
+1,482
| +124% | +$99K | ﹤0.01% | 2224 |
|
2024
Q1 | $84.7K | Buy |
1,191
+265
| +29% | +$18.8K | ﹤0.01% | 2321 |
|
2023
Q4 | $78K | Sell |
926
-1,008
| -52% | -$84.9K | ﹤0.01% | 2382 |
|
2023
Q3 | $166K | Hold |
1,934
| – | – | ﹤0.01% | 2230 |
|
2023
Q2 | $180K | Buy |
1,934
+1,006
| +108% | +$93.8K | ﹤0.01% | 2221 |
|
2023
Q1 | $87.9K | Hold |
928
| – | – | ﹤0.01% | 2376 |
|
2022
Q4 | $93.3K | Sell |
928
-95
| -9% | -$9.55K | ﹤0.01% | 2370 |
|
2022
Q3 | $87K | Sell |
1,023
-13
| -1% | -$1.11K | ﹤0.01% | 2500 |
|
2022
Q2 | $89K | Sell |
1,036
-43
| -4% | -$3.69K | ﹤0.01% | 2475 |
|
2022
Q1 | $97K | Buy |
1,079
+49
| +5% | +$4.41K | ﹤0.01% | 2519 |
|
2021
Q4 | $103K | Sell |
1,030
-20
| -2% | -$2K | ﹤0.01% | 2572 |
|
2021
Q3 | $97K | Sell |
1,050
-130
| -11% | -$12K | ﹤0.01% | 2622 |
|
2021
Q2 | $100K | Hold |
1,180
| – | – | ﹤0.01% | 2601 |
|
2021
Q1 | $102K | Buy |
+1,180
| New | +$102K | ﹤0.01% | 2603 |
|
2020
Q2 | – | Sell |
-3,392
| Closed | -$320K | – | 3264 |
|
2020
Q1 | $320K | Buy |
3,392
+1,708
| +101% | +$161K | ﹤0.01% | 2226 |
|
2019
Q4 | $182K | Buy |
1,684
+323
| +24% | +$34.9K | ﹤0.01% | 2335 |
|
2019
Q3 | $130K | Buy |
+1,361
| New | +$130K | ﹤0.01% | 2358 |
|